Gabapentin
Product Images NDC 50436-0384

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50436-0384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504360383)

This is a medication description for Gabapentin, USP, containing 100mg per capsule. The manufacturer is ScieGen Pharmaceutical, Inc., located in Hauppauge, NY. The medication is dispensed in a tight container with a child-resistant dosage, and each package insert contains dosage information for the patient. The medication should be kept out of reach of children and stored at a temperature between 20 to 25°C. The drug is available by prescription only. There are several NDC codes and lot numbers listed, but no other relevant information.*

FDA Label Image

Label Image (Lbl504360384)

This is a package of Gabapentin medication. The NDC number is 50436-0384-4 and each package contains 24 capsules of Gabapentin, with each capsule containing 300mg of the active ingredient. The medication is distributed by ScieGen Pharmaceutical, Inc. and should be dispensed to patients by a pharmacist along with a medication guide. The lot number is 5000000 and it should be kept out of reach of children. Dosage information can be found in the package insert. There are also other packages of Gabapentin listed with different lot numbers.*

FDA Label Image

Clcr Calculation (Spl Image1 Clcr Calc)

This is a formula used to estimate the glomerular filtration rate (GFR) of a patient by using their age, weight, and serum creatinine level. The formula is different for female patients, who need to multiply the result by 0.85. However, without further context or information, it is not possible to determine the specific medical condition or purpose for which this formula is being used.*

FDA Label Image

Structure (Spl Image2 Structure)

FDA Label Image

Figure (Spl Image3 Figure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.